"I was expecting him probably to win. It was very big win," Pfizer's CEO Albert Bourla said of President Donald Trump's ...

Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in the United ...

Eli Lilly also responded to the President's tariff warnings by investing $27 billion to construct four manufacturing ...

Pfizer CEO Albert Bourla on Monday said that the company might move overseas manufacturing to its existing plants in the ...

Pfizer (PFE) may move overseas manufacturing to its existing plants in the U.S., if required, as the Trump administration threatens numerous ...

Pfizer CEO Albert Bourla said the drugmaker might move overseas manufacturing to its plants in the U.S. as Trump threatens ...

Trump's tariff hike on Chinese goods may tighten margins for generic drugmakers relying on Chinese APIs. Read more here.

The pharmaceutical industry is undergoing a paradigm shift, driven by cutting-edge technologies and new digital capabilities.

Pfizer's CEO says he's got a plan to deal with Trump's tariffs — move overseas drug manufacturing to the US Bears Predicted ...

Bears Predicted To Give Ben Johnson a New ‘Sonic and Knuckles’ Duo by Taking 32-TD RB Early in 2025 NFL Draft ...

In recent weeks, some companies raced to get ahead of tariffs with pre-ordering of goods, but executives have until now been ...

Canada and Mexico get hit with 25% tariffs in the latest shakeup from the Trump administration, while taxes on China's goods ...